Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 107 results.
User Information
Export Records
  1. 1.   A patient-derived cell model for malignant transformation in IDH-mutant glioma
  2. Kim, Olga; Sergi, Zach; Yu, Guangyang; Yamamoto, Kazutoshi; Quezado, Martha; Abdullaev, Zied; Crooks, Danel R; Kishimoto, Shun; Li, Qi; Lu, Peng; Blackman, Burchelle; Andresson,Thorkell; Wu,Xiaolin; Tran,Bao; Wei, Jun S; Zhang, Wei; Zhang, Meili; Song, Hua; Khan, Javed; Krishna, Murali C; Brender, Jeffrey R; Wu, Jing
  3. Acta Neuropathologica Communications. 2024, Sep 10; 12(1): 148.
  1. 2.   Tumor suppressor ATP4B serve as a promising biomarker for worsening of gastric atrophy and poor differentiation
  2. Pan, Yuanming; Wang, Xin; He, Yuqi; Lin, Shuye; Zhu, Min; Li, Yangjie; Wang, Jianxun; Wang, Jiheng; Ma, Xianzong; Xu, Junfeng; Yang, Lang; Yang, Guibin; Huang, Jiaqiang; Lu, Youyong; Sheng, Jianqiu
  3. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 2020, Oct 27;
  1. 3.   Rare germline variants in known melanoma susceptibility genes in familial melanoma
  2. Goldstein, Alisa M.; Xiao, Yanzi; Sampson, Joshua; Zhu, Bin; Rotunno, Melissa; Bennett, Hunter; Wen, Yixuan; Jones, Kristine; Vogt, Aurelie; Burdette, Laurie; Luo, Wen; Zhu, Bin; Yeager, Meredith; Hicks, Belynda; Han, Jiali; De Vivo, Immaculata; Koutros, Stella; Andreotti, Gabriella; Beane-Freeman, Laura; Purdue, Mark; Freedman, Neal D.; Chanock, Stephen J.; Tucker, Margaret A.; Yang, Xiaohong R.
  3. Human Molecular Genetics. 2017, Dec 15; 26(24): 4886-4895.
  1. 4.   Characterization of two mouse models of metastatic pheochromocytoma using bioluminescence imaging
  2. Giubellino, A.; Woldemichael, G. M.; Sourbier, C.; Lizak, M. J.; Powers, J. F.; Tischler, A. S.; Pacak, K.
  3. Cancer Letters. 2012, Mar; 316(1): 46-52.
  1. 5.   MG-2477, a new tubulin inhibitor, induces autophagy through inhibition of the Akt/mTOR pathway and delayed apoptosis in A549 cells
  2. Viola, G.; Bortolozzi, R.; Hamel, E.; Moro, S.; Brun, P.; Castagliuolo, I.; Ferlin, M. G.; Basso, G.
  3. Biochemical Pharmacology. 2012, Jan; 83(1): 16-26.
  1. 6.   Real-time PCR-based assay to quantify the relative amount of human and mouse tissue present in tumor xenografts
  2. Alcoser, S. Y.; Kimmel, D. J.; Borgel, S. D.; Carter, J. P.; Dougherty, K. M.; Hollingshead, M. G.
  3. BMC Biotechnology. 2011, Dec; 11
  1. 7.   HER2-Affitoxin: A Potent Therapeutic Agent for the Treatment of HER2-Overexpressing Tumors
  2. Zielinski, R.; Lyakhov, I.; Hassan, M.; Kuban, M.; Shafer-Weaver, K.; Gandjbakhche, A.; Capala, J.
  3. Clinical Cancer Research. 2011, Aug; 17(15): 5071-5081.
  1. 8.   The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling
  2. Ping, Y. F.; Yao, X. H.; Jiang, J. Y.; Zhao, L. T.; Yu, S. C.; Jiang, T.; Lin, M. C. M.; Chen, J. H.; Wang, B.; Zhang, R.; Cui, Y. H.; Qian, C.; Wang, J. M.; Bian, X. W.
  3. Journal of Pathology. 2011, Jul; 224(3): 344-354.
  1. 9.   Plasma and CNS pharmacokinetics of O(4)-benzylfolic acid (O(4)BF) and metabolite in a non-human primate model
  2. Chuk, M. K.; Cole, D. E.; McCully, C.; Loktionova, N. A.; Pegg, A. E.; Parker, R. J.; Pauly, G.; Widemann, B. C.; Balis, F. M.; Fox, E.
  3. Cancer Chemotherapy and Pharmacology. 2011, Jun; 67(6): 1291-1297.
  1. 10.   Phase I trial of vandetanib and bevacizumab evaluating the VEGF and EGF signal transduction pathways in adults with solid tumours and lymphomas
  2. Kummar, S.; Gutierrez, M. E.; Chen, A.; Turkbey, I. B.; Allen, D.; Horneffer, Y. R.; Juwara, L.; Cao, L.; Yu, Y. K.; Kim, Y. S.; Trepel, J.; Chen, H.; Choyke, P.; Melillo, G.; Murgo, A. J.; Collins, J.; Doroshow, J. H.
  3. European Journal of Cancer. 2011, May; 47(7): 997-1005.
  1. 11.   Differential effects of nitric oxide on blood-brain barrier integrity and cerebral blood flow in intracerebral C6 gliomas
  2. Weyerbrock, A.; Walbridge, S.; Saavedra, J. E.; Keefer, L. K.; Oldfield, E. H.
  3. Neuro-Oncology. 2011, Feb; 13(2): 203-211.
  1. 12.   Interferon-gamma links ultraviolet radiation to melanomagenesis in mice
  2. Zaidi, M. R.; Davis, S.; Noonan, F. P.; Graff-Cherry, C.; Hawley, T. S.; Walker, R. L.; Feigenbaum, L.; Fuchs, E.; Lyakh, L.; Young, H. A.; Hornyak, T. J.; Arnheiter, H.; Trinchieri, G.; Meltzer, P. S.; De Fabo, E. C.; Merlino, G.
  3. Nature. 2011, Jan; 469(7331): 548-U129.
  1. 13.   Molecular Evolutionary Analysis of ABCB5: The Ancestral Gene Is a Full Transporter with Potentially Deleterious Single Nucleotide Polymorphisms
  2. Moitra, K.; Scally, M.; McGee, K.; Lancaster, G.; Gold, B.; Dean, M.
  3. Plos One. 2011, Jan; 6(1): 12.
  1. 14.   The Development and Characterization of a Human Mesothelioma In Vitro 3D Model to Investigate Immunotoxin Therapy
  2. Xiang, X. R.; Phung, Y.; Feng, M. Q.; Nagashima, K.; Zhang, J. L.; Broaddus, V. C.; Hassan, R.; FitzGerald, D.; Ho, M.
  3. Plos One. 2011, Jan; 6(1): 10.
  1. 15.   Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine
  2. Libutti, S. K.; Paciotti, G. F.; Byrnes, A. A.; Alexander, H. R.; Gannon, W. E.; Walker, M.; Seidel, G. D.; Yuldasheva, N.; Tamarkin, L.
  3. Clinical Cancer Research. 2010, Dec; 16(24): 6139-6149.
  1. 16.   Fullerenol cytotoxicity in kidney cells is associated with cytoskeleton disruption, autophagic vacuole accumulation, and mitochondrial dysfunction
  2. Johnson-Lyles, D. N.; Peifley, K.; Lockett, S.; Neun, B. W.; Hansen, M.; Clogston, J.; Stern, S. T.; McNeil, S. E.
  3. Toxicology and Applied Pharmacology. 2010, Nov; 248(3): 249-258.
  1. 17.   The role of miR-31 and its target gene SATB2 in cancer-associated fibroblasts
  2. Aprelikova, O.; Yu, X. A.; Palla, J.; Wei, B. R.; John, S.; Yi, M.; Stephens, R.; Simpson, R. M.; Risinger, J. I.; Jazaeri, A.; Niederhuber, J.
  3. Cell Cycle. 2010, Nov; 9(21): 4387-4398.
  1. 18.   Optimized combination therapy using bortezomib, TRAIL and TLR agonists in established breast tumors
  2. Lee, S.; Yagita, H.; Sayers, T. J.; Celis, E.
  3. Cancer Immunology Immunotherapy. 2010, Jul; 59(7): 1073-1081.
  1. 19.   Mutagenicity of N-ethyl-N-nitrosourea, N-methyl-N-nitrosourea, methyl methanesulfonate and ethyl methanesulfonate in the developing Syrian hamster fetus
  2. Donovan, P.; Smith, G.
  3. Mutation Research-Genetic Toxicology and Environmental Mutagenesis. 2010, Jun; 699(1-2): 55-57.
  1. 20.   Schweinfurthin A Selectively Inhibits Proliferation and Rho Signaling in Glioma and Neurofibromatosis Type 1 Tumor Cells in a NF1-GRD-Dependent Manner
  2. Turbyville, T. J.; Gursel, D. B.; Tuskan, R. G.; Walrath, J. C.; Lipschultz, C. A.; Lockett, S. J.; Wiemer, D. F.; Beutler, J. A.; Reilly, K. M.
  3. Molecular Cancer Therapeutics. 2010, May; 9(5): 1234-1243.
  1. 21.   In vitro comparison of O4-benzylfolate modulated, BCNU-induced toxicity in human bone marrow using CFU-GM and tumor cell lines
  2. Behrsing, H. P.; Furniss, M. J.; Robillard, K. A.; Tomaszewski, J. E.; Parchment, R. E.
  3. Cancer Chemotherapy and Pharmacology. 2010, May; 65(6): 1083-1091.
  1. 22.   The G-protein-coupled formylpeptide receptor FPR confers a more invasive phenotype on human glioblastoma cells
  2. Huang, J.; Chen, K.; Chen, J.; Gong, W.; Dunlop, N. M.; Howard, O. M. Z.; Gao, Y.; Bian, X. W.; Wang, J. M.
  3. British Journal of Cancer. 2010, Mar 16; 102(6): 1052-1060.
  1. 23.   HER2-and EGFR-Specific Affiprobes: Novel Recombinant Optical Probes for Cell Imaging
  2. Lyakhov, I.; Zielinski, R.; Kuban, M.; Kramer-Marek, G.; Fisher, R.; Chertov, O.; Bindu, L.; Capala, J.
  3. Chembiochem. 2010, Feb; 11(3): 345-350.
  1. 24.   Arsenic Exposure Transforms Human Epithelial Stem/Progenitor Cells into a Cancer Stem-like Phenotype
  2. Tokar, E. J.; Diwan, S. A.; Waalkes, M. P.
  3. Environmental Health Perspectives. 2010, Jan; 118(1): 108-115.
  1. 25.   Bioluminescent Approaches for Measuring Tumor Growth in a Mouse Model of Neurofibromatosis
  2. Hawes, J. J.; Reilly, K. M.
  3. Toxicologic Pathology. 2010, Jan; 38(1): 123-130.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel